
CAS 927819-64-5
:Formula:C31H41N3O7
InChI:InChI=1S/C31H41N3O7/c35-28(34-21-9-15-27(34)31(40)41)24(33-26(30(38)39)19-17-23-12-5-2-6-13-23)14-7-8-20-32-25(29(36)37)18-16-22-10-3-1-4-11-22/h1-6,10-13,24-27,32-33H,7-9,14-21H2,(H,36,37)(H,38,39)(H,40,41)/t24-,25?,26-,27-/m0/s1
InChI key:MKOWVLMGJKGFMF-MBKURTIGSA-N
SMILES:C1C[C@H](N(C1)C(=O)[C@H](CCCCNC(CCC2=CC=CC=C2)C(=O)O)N[C@@H](CCC3=CC=CC=C3)C(=O)O)C(=O)O
Filtra per
Percentuale di purezza
0
100
|
0
|
50
|
90
|
95
|
100
Trovati 5 prodotti.
- Prezzo più basso
- Prezzo più alto
- Purezza più bassa
- Purezza più alta
- Consegna più veloce
Lisinopril EP Impurity I
CAS:Formula:C31H41N3O7Colore e forma:White To Off-White SolidPeso molecolare:567.68N2-((S)-1-Carboxy-3-phenylpropyl)-N6-(1-carboxy-3-phenylpropyl)-L-lysyl-L-proline
CAS:Formula:C31H41N3O7Purezza:97%Peso molecolare:567.67N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers)
CAS:Prodotto controllatoApplications N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers) is an impurity of lisinopril (L468985), an orally active angiotensin-converting enzyme (ACE) inhibitor.
References Shinde, V., et. al.: J. Pharm. Biomed. Anal., 43, 381 (2007); Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)Formula:C31H41N3O7Colore e forma:NeatPeso molecolare:567.67Lisinopril EP Impurity I
CAS:Lisinopril EP Impurity I is an impurity of the drug lisinopril. It is a natural product that has been synthesized for use as an analytical standard for pharmacological research and development. Lisinopril EP Impurity I is a synthetic compound that was custom-synthesized from amino acid derivatives and has been used in the manufacture of pharmaceuticals as an impurity standard, including as a high purity HPLC standard. This impurity has been shown to be less toxic than other lisinopril epimerization products, such as lisinopril epimerization product II, which can cause renal toxicity. Lisinopril EP Impurity I also has anti-inflammatory effects and can inhibit LPS-induced production of nitric oxide by macrophages.Formula:C31H41N3O7Purezza:Min. 95%Peso molecolare:567.7 g/molRef: ST-EA-CP-L21009
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta





